Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

Zachariah DeFilipp, Richard Ancheta, Ying Liu, Zhen Huan Hu, Robert Peter Gale, David Snyder, Harry C. Schouten, Matt Kalaycio, Gerhard C. Hildebrandt, Celalettin Ustun, Andrew Daly, Siddhartha Ganguly, Yoshihiro Inamoto, Mark Litzow, Jeffrey Szer, Mary Lynn Savoie, Nasheed Hossain, Mohamed A. Kharfan-Dabaja, Mehdi Hamadani, Ran ReshefAshish Bajel, Kirk R. Schultz, Shahinaz Gadalla, Aaron Gerds, Jane Liesveld, Mark B. Juckett, Rammurti Kamble, Shahrukh Hashmi, Hisham Abdel-Azim, Melhem Solh, Ulrike Bacher, Hillard Lazarus, Richard Olsson, Jean Yves Cahn, Michael R. Grunwald, Bipin N. Savani, Jean Yared, Jacob M. Rowe, Jan Cerny, Naeem A. Chaudhri, Mahmoud Aljurf, Amer Beitinjaneh, Sachiko Seo, Taiga Nishihori, Jack W. Hsu, Muthalagu Ramanathan, Edwin Alyea, Uday Popat, Ronald Sobecks, Wael Saber

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)472-479
Number of pages8
JournalBiology of Blood and Marrow Transplantation
Volume26
Issue number3
DOIs
StatePublished - Mar 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology
  • Transplantation

Keywords

  • Allogeneic hematopoietic cell transplantation
  • Chronic myelogenous leukemia
  • Maintenance
  • Tyrosine kinase inhibitor

Cite this